• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    4.00 Down 0.19(4.53%) Apr 29, 4:00PM EDT
    |After Hours : 4.28 Up 0.28 (7.00%) Apr 29, 7:41PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue 1,791   1,025   2,178   486  
    Cost of Revenue -   -   -   -  
    Gross Profit 1,791   1,025   2,178   486  
    Operating Expenses
    Research Development23,900  24,656  26,490  25,125  
    Selling General and Administrative11,076  8,488  8,184  6,089  
    Non Recurring -   -   -   -  
    Others253  253  254  253  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (33,438) (32,372) (32,750) (30,981)
    Income from Continuing Operations
    Total Other Income/Expenses Net754  392  391  807  
    Earnings Before Interest And Taxes(32,684)(31,980)(32,359)(30,174)
    Interest Expense -   -   -   -  
    Income Before Tax(32,684)(31,980)(32,359)(30,174)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(32,684)(31,980)(32,359)(30,174)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (32,684) (31,980) (32,359) (30,174)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (32,684) (31,980) (32,359) (30,174)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.